Search PubMed⌕ Search

Biomedical subjects

C Price

Publications and source records attributed to C Price.

At least 163 records · Page 9Linked to original sources
PubMed1988

Q fever following bone marrow transplantation.

We describe a patient who developed an acute febrile illness 85 days after receiving an allogeneic bone marrow transplant for acute myeloid leukaemia. Serological investigation indicated the cause to be Q fever. The patient was receiving concurrent immunosuppressive therapy for graft-versus-host disease (GVHD). Coxiella burnetii should be added to the list of organisms which may complicate bone marrow transplantation. This case also provides further evidence to support an association between immunocompromised conditions and the development of Q fever.

Adult↗
PubMed1987

EcoR124 and EcoR124/3: the first members of a new family of type I restriction and modification systems.

We have purified the EcoR124 and EcoR124/3 restriction enzymes and shown that they are type I enzymes by several criteria: subunit composition, DNA and S-adenosylmethionine-dependent ATPase activity, and site-specific DNA methylase activity. By immunochemical criteria these enzymes are related to each other but are unrelated to the two previously investigated families of type I restriction enzymes. They form therefore a new family which we call type IC. The arrangement of the structural genes coding for these enzymes and their transcriptional organisation have been determined. These are different from the common arrangement found for the other two families of type I enzymes.

Adenosine Triphosphatases↗
PubMed1987

Endorphins are related to pain perception in coronary artery disease.

Plasma beta-endorphin levels were measured by radioimmunoassay before and after exercise in 25 patients with coronary artery disease. Eighteen patients were men and 7 were women; age range was 36 to 75 years (mean 60). All patients had angina pectoris, a positive treadmill test response or positive exercise radionuclide findings. The mean preexercise plasma endorphin level was 4.9 +/- 3.0 pmol/liter (range 0.7 to 13.5). The mean postexercise plasma endorphin level of 6.6 +/- 4.6 mol/liter (range 0 to 19.5) was significantly higher (p less than 0.05). A significant positive correlation was seen between postexercise endorphin levels and time to onset of angina (r = 0.4, p = 0.03). There were negative correlations between postexercise endorphin levels and occurrence (r = -0.4, p = 0.04) and duration of angina (r = -0.4, p = 0.05). No association was found for maximal heart rate-blood pressure product, workload, time to ST-segment depression or stress ejection fraction. A positive correlation was found between rest left ventricular ejection fraction and postexercise endorphin levels (r = 0.5, p = 0.02). In conclusion, in patients with exercise-induced myocardial ischemia, plasma beta-endorphin levels are increased after exercise; postexercise endorphin levels are related to timing and occurrence (presence or absence) of angina; and endorphins may alter the perception of pain caused by myocardial ischemia.

Adult↗
PubMed1987

DNA recognition by a new family of type I restriction enzymes: a unique relationship between two different DNA specificities.

The DNA sequences recognized by the allelic type I restriction enzymes EcoR124 and EcoR124/3 were determined. EcoR124 recognizes 5'-GAA(N6)RTCG-3' and EcoR124/3 recognizes 5'-GAA(N7)RTCG-3'. These are typical of sequences recognized by type I recognition enzymes in that they consist of two specific domains separated by a non-specific spacer sequence. For these two enzymes, the specific sequences are identical but the length of the non-specific spacer is different. The specific domains of EcoR124/3 are thus 3.4 A further apart than those of EcoR124 and rotated with respect to each other through a further 36 degrees.

Base Sequence↗
PubMed1986

A method of determining the radiopacity of dental materials and foreign bodies.

The desirability of radiopacity in dental materials and other materials that may become foreign bodies is documented. No simple, reliable methods are available for the determination of radiopacity, and no standard specifications have been devised with regard to the radiopacity of dental materials. A method that enables radiopacity to be determined is described. The theoretical aspects of radiopacity in relation to the method are considered. Possible applications of this method in the development of standards for radiopacity are suggested.

Absorptiometry, Photon↗
PubMed1986

The effects of beam quality and optical density on image quality in dental radiography.

The literature relating to the choice of beam quality in dental radiography is reviewed. Twenty observers were asked to select radiographs of a test object at different beam qualities and densities. The same observers were asked to identify numbers of circular areas of small density differences in zones of high and low density. Subjectively, the observers favored radiographs produced with lower beam energies; 90 kVp aluminum filtration and 3.5 mm was least popular, and 70 kVp with 2.5 mm aluminum was most popular. Objectively, there was little difference in the success of identification between the beams of different energies. Masking of radiographs improved success apart from the low density zones in less exposed radiographs. Little evidence has been found within the range investigated for selecting one beam quality over another, other than subjective preference. However, low beam energies should be avoided because of reduced emulsion sensitivity.

Densitometry↗
PubMed1986

Scattered radiation grids in cephalometric radiography.

Scattered radiation grids are routinely used in medical radiological examinations of the skull, but less commonly in cephalometric radiography. Because the grids involve an increased radiation dose, it is necessary to determine whether the diagnostic quality of cephalometric radiographs is improved by a grid to an extent that justifies this increased dose. This investigation has failed to demonstrate any improvement in the identification of five landmarks. It is thus concluded that there is no justification for the use of scattered radiation grids in cephalometric radiography.

Adult↗
PubMed1986

Facial morphology and obstructive sleep apnea.

In a sample of 25 adult male subjects with moderate to severe obstructive sleep apnea, the interaction among craniofacial, airway, tongue, and hyoid variables was quantified by means of a canonical correlation analysis. One lateral cephalometric radiograph with the teeth in occlusion was obtained for each subject together with overnight polysomnographic measurements before the initiation of therapy. A principal component analysis reduced the data base and one significant canonical correlation (r1 = 0.994) was identified for the 22 variables. Sleep apnea subjects showed a posteriorly positioned maxilla and mandible, a steep occlusal plane, overerupted maxillary and mandibular teeth, proclined incisors, a steep mandibular plane, a large gonial angle, high upper and lower facial heights, and an anterior open bite in association with a long tongue and a posteriorly placed pharyngeal wall. A multivariate statistical analysis extracted clinically significant associations among craniofacial, tongue, and airway variables. Subjects with sleep apnea demonstrated several alterations in craniofacial form that may reduce the upper airway dimensions and subsequently impair upper airway stability.

Adult↗
PubMed1985

The EcoR124 and EcoR124/3 restriction and modification systems: cloning the genes.

The Escherichia coli plasmid R124 codes for a type I restriction and modification system EcoR124 and carries genetic information, most probably in the form of a "silent copy," for the expression of a different R-M specificity R124/3. Characteristic DNA rearrangements have been shown to accompany the switch in specificity from R124 to R124/3 and vice versa. We have cloned a 14.2-kb HindIII fragment from R124 and shown that it contains the hsdR, hsdM, and hsdS genes which code for the EcoR124 R-M system. An equivalent fragment from the plasmid R124/3 following the switch in R-M specificity has also been cloned and shown to contain the genes coding for the EcoR124/3 R-M system. These fragments, however, lack a component present on the wild-type plasmid essential for the switch in specificity. Restriction fragment maps and preliminary heteroduplex analysis indicate the near identity of the genes that encode the two different DNA recognition specificities. Transposon mutagenesis was used to locate the positions of the hsdR, hsdM, and hsdS genes on the cloned fragments in conjunction with complementation tests for gene function. Indirect evidence indicates that hsdR is expressed from its own promoter and that hsdM and hsdS are expressed from a single promoter, unidirectionally.

Cloning, Molecular↗
PubMed1985

A psychophysical analysis of morphine analgesia.

Intravenous administration of 0.04-0.08 mg/kg morphine sulfate reduced both sensory intensity and unpleasantness visual analogue scale (VAS) responses to graded 5 sec nociceptive temperature stimuli (45-51 degrees C) in a dose-dependent manner. The lower doses of morphine (0.04 and 0.06 mg/kg) resulted in statistically reliable reductions in affective but not sensory intensity VAS responses, possibly reflecting supraspinal effects on brain regions involved in affect and motivation. However, the highest dose of morphine tested (0.08 mg/kg) reduced both sensory and affective VAS responses to graded nociceptive stimuli as well as VAS sensory responses to first and second pain evoked by brief heat pulses. Morphine also had an especially potent inhibitory effect on temporal summation of second pain that is known to occur when intense nociceptive stimuli occur at rates greater than 0.3/sec. The results support current hypotheses about neural mechanisms of narcotic analgesia and further clarify the relative effects of morphine on sensory and affective dimensions of experimental pain. The derived morphine dose-analgesic response functions also provide a reference standard for quantitatively comparing magnitudes of different CNS-mediated forms of analgesia.

Adult↗
PubMed1985

Potentiation of systemic morphine analgesia in humans by proglumide, a cholecystokinin antagonist.

Proglumide, a cholecystokinin antagonist, potentiates analgesia produced in rats by morphine and endogenous opiates, and appears to reverse tolerance in rats to opiate analgesia. Therefore, proglumide and other cholecystokinin antagonists may be clinically valuable. We have tested proglumide's possible opiate analgesic potentiating effects by examining, in volunteers, the effects of morphine and proglumide on human pain visual analogue scale responses to 45-51 degrees C skin temperature stimuli. Proglumide (50-100 micrograms intravenously) potentiated both the magnitude and duration of analgesia produced by small doses of morphine. This study provides indirect evidence for a cholecystokinin-opiate interaction in humans. Therefore, cholecystokinin antagonists such as proglumide may serve to potentiate exogenous or endogenous opiate action.

Adult↗